Dr. Wayne Batchelor currently serves as System Director of Interventional Cardiology, Director of Interventional Research and Education at Inova and as Senior Associate Director at Inova Schar Heart and Vascular in Fairfax, VA. He is a Professor of Medicine at Duke University, Chair of the American College of Cardiology's Interventional Sectional Leadership Council, and Vice Chair of the U.S. Society of Thoracic Surgery and American College of Cardiology’s Transcatheter Valve Therapy Registry.

Dr. Batchelor is board certified in cardiovascular disease with added qualifications in interventional cardiology. His interest in interventional cardiology stems from the ability to combine direct patient care, intervention and innovation within a single field. His goal is to help patients achieve optimal outcomes through the prudent application of the most state-of-the-art and technically advanced minimally invasive cardiovascular procedures. He joined Inova with more than 20 years of clinical and research experience and is an internationally recognized expert in the treatment of acute myocardial infarction, cardiogenic shock, complex or high-risk percutaneous coronary intervention, structural/valvular heart disease, clinical trials in cardiovascular disease, and cardiovascular healthcare disparities.

Dr. Batchelor has published over 200 peer-reviewed original abstracts and manuscripts, authored multiple book chapters, served on numerous national and international clinical trial steering committees, and as national principal investigator on multiple trials. He is a senior advisor and often a guest editor for the Journal of the American College of Cardiology and serves on the editorial boards of Circulation, the Journal of the Society of Cardiovascular Angiography, and Interventions and Cardiovascular Revascularization Medicine. Dr. Batchelor is also a special consultant to the U.S. Food and Drug Administration within the cardiovascular devices branch.

In his spare time, he enjoys spending time with his family and two miniature schnauzers.

Awards/Associations

• Capital Medical Society's Outstanding Physician of the Year Award
• Sopman Award for Clinical Excellence and Human Compassion
• Fellow of the American College of Cardiology
• Fellow of the Society for Cardiac Angiography and Interventions

Blog Posts

Inova plays a key role in trial of innovative treatment for tricuspid valve regurgitation that is now approved by the FDA (April 2024)

A minimally invasive option for pulmonary regurgitation (July 2023)

Inova study offers new treatment for tricuspid valve regurgitation (March 2021)

Health disparities in aortic stenosis: Closing the treatment gap (February 2020)

Podcasts

Should you take aspirin to prevent heart attacks? (June 2019)